Abstract
Whole exome sequencing (WES) is an integral tool in the diagnosis of genetic conditions in pediatric patients, but concerns have been expressed about the complexity of the information and the possibility for secondary findings that need to be conveyed to those deciding about WES. Currently, there is no validated tool to assess parental understanding of WES. We developed and implemented a survey to assess perceived and actual understanding of WES in parents who consented to clinical WES for their child between July 2013 and May 2015. Fifty-three eligible surveys were returned (57% response rate). Areas with both low perceived and actual understanding about WES included how genes are analyzed and lack of protection against life insurance discrimination. Parents also had low actual understanding for two questions related to secondary findings – reporting of secondary findings in a parent (if tested) and whether secondary findings can be related to traits such as height and hair color. Further work to develop a validated tool to assess understanding of WES would be beneficial as WES is integrated more frequently into clinical care.
Similar content being viewed by others
References
ACMG Board of Directors (2013). Points to consider for informed consent for genome/exome sequencing. Genetics in Medicine, 15(9), 748–749. doi:10.1038/gim.2013.94.
Allyse, M., & Michie, M. (2013). Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing. Trends in Biotechnology, 31(8), 439–441. doi:10.1016/j.tibtech.2013.04.006.
Appelbaum, P. S., Waldman, C. R., Fyer, A., Klitzman, R., Parens, E., Martinez, J., et al. (2014). Informed consent for return of incidental findings in genomic research. Genetics in Medicine, 16(5), 367–373. doi:10.1038/gim.2013.145.
Armstrong, K., Weber, B., FitzGerald, G., Hershey, J. C., Pauly, M. V., Lemaire, J., et al. (2003). Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination. American Journal of Medical Genetics. Part A, 120a(3), 359–364. doi:10.1002/ajmg.a.20025.
Ayuso, C., Millan, J. M., Mancheno, M., & Dal-Re, R. (2013). Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process. European Journal of Human Genetics, 21(10), 1054–1059. doi:10.1038/ejhg.2012.297.
Barlow-Stewart, K., Taylor, S. D., Treloar, S. A., Stranger, M., & Otlowski, M. (2009). Verification of consumers’ experiences and perceptions of genetic discrimination and its impact on utilization of genetic testing. Genetics in Medicine, 11(3), 193–201. doi:10.1097/GIM.0b013e318194ee75.
Beauchamp, T. L., & Faden, R. R. (1995). Informed consent: II. Meaning and elements of informed consent. In R. WT (Ed.), Encyclopaedia of bioethics (Vol. 14, pp. 1240–1245). New York: Simon & Schuster Macmillan.Revised
Bergner, A. L., Bollinger, J., Raraigh, K. S., Tichnell, C., Murray, B., Blout, C. L., et al. (2014). Informed consent for exome sequencing research in families with genetic disease: the emerging issue of incidental findings. American Journal of Medical Genetics. Part A, 164(11), 2745–2752. doi:10.1002/ajmg.a.36706.
Bernhardt, B. A., Roche, M. I., Perry, D. L., Scollon, S. R., Tomlinson, A. N., & Skinner, D. (2015). Experiences with obtaining informed consent for genomic sequencing. American Journal of Medical Genetics. Part A, 167a(11), 2635–2646. doi:10.1002/ajmg.a.37256.
Bick, D., & Dimmock, D. (2011). Whole exome and whole genome sequencing. Current Opinion in Pediatrics, 23(6), 594–600. doi:10.1097/MOP.0b013e32834b20ec.
Bigby, C. (1996). Transferring responsibility: the nature and effectiveness of parental planning for the future of adults with intellectual disability who remain at home until mid-life. Journal of Intellectual and Developmental Disability, 21(4), 295–312. doi:10.1080/13668259600033211.
Bowdin, S., Ray, P. N., Cohn, R. D., & Meyn, M. S. (2014). The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care. Human Mutation, 35(5), 513–519. doi:10.1002/humu.22536.
Bradbury, A. R., Patrick-Miller, L., & Domchek, S. (2015). Multiplex genetic testing: reconsidering utility and informed consent in the era of next-generation sequencing. Genetics in Medicine, 17(2), 97–98. doi:10.1038/gim.2014.85.
Bunnik, E. M., Janssens, A. C., & Schermer, M. H. (2014). Informed consent in direct-to-consumer personal genome testing: the outline of a model between specific and generic consent. Bioethics, 28(7), 343–351. doi:10.1111/bioe.12004.
Burke, W., Matheny Antommaria, A. H., Bennett, R., Botkin, J., Clayton, E. W., Henderson, G. E., et al. (2013). Recommendations for returning genomic incidental findings? We need to talk! Genetics in Medicine, 15(11), 854–859. doi:10.1038/gim.2013.113.
Elias, S., & Annas, G. J. (1994). Generic consent for genetic screening. The New England Journal of Medicine, 330(22), 1611–1613.
Essex, E. L., Seltzer, M. M., & Krauss, M. W. (1999). Differences in coping effectiveness and well-being among aging mothers and fathers of adults with mental retardation. American Journal of Mental Retardation, 104(6), 545–563. doi:10.1352/0895-8017(1999)104<0545:diceaw>2.0.co;2.
Farwell, K. D., Shahmirzadi, L., El-Khechen, D., Powis, Z., & Chao, E. C. (2014). Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genetics in Medicine. doi:10.1038/gim.2014.154.
Goldenberg, A. J., Dodson, D. S., Davis, M. M., & Tarini, B. A. (2014). Parents’ interest in whole-genome sequencing of newborns. Genetics in Medicine, 16(1), 78–84. doi:10.1038/gim.2013.76.
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565–574. doi:10.1038/gim.2013.73.
Grody, W. W., Thompson, B. H., & Hudgins, L. (2013). Whole-exome/genome sequencing and genomics. Pediatrics, 132(Suppl 3), S211–S215. doi:10.1542/peds.2013-1032E.
Harris, P., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. (2009). Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381.
Joffe, S., Cook, E. F., Cleary, P. D., Clark, J. W., & Weeks, J. C. (2001). Quality of informed consent: a new measure of understanding among research subjects. Journal of the National Cancer Institute, 93(2), 139–147.
Johansen Taber, K. A., Dickinson, B. D., & Wilson, M. (2014). The promise and challenges of next-generation genome sequencing for clinical care. JAMA Internal Medicine, 174(2), 275–280. doi:10.1001/jamainternmed.2013.12048.
Johnson, K. J., & Gehlert, S. (2014). Return of results from genomic sequencing: a policy discussion of secondary findings for cancer predisposition. Journal of Cancer Policy, 2(3), 75–80. doi:10.1016/j.jcpo.2014.05.001.
Joly, Y., Ngueng Feze, I., & Simard, J. (2013). Genetic discrimination and life insurance: a systematic review of the evidence. BMC Medicine, 11, 25. doi:10.1186/1741-7015-11-25.
Joseph, G., Chen, F., Harris-Wai, J., Puck, J. M., Young, C., & Koenig, B. A. (2016). Parental views on expanded newborn screening using whole-genome sequencing. Pediatrics, 137(Suppl 1), S36–S46. doi:10.1542/peds.2015-3731H.
Kai, J. (1996). Parents’ difficulties and information needs in coping with acute illness in preschool children: a qualitative study. BMJ, 313(7063), 987–990.
Kingsmore, S. F., & Saunders, C. J. (2011). Deep sequencing of patient genomes for disease diagnosis: when will it become routine? Science Translational Medicine, 3(87), 87ps23. doi:10.1126/scitranslmed.3002695.
Klima, J., Fitzgerald-Butt, S. M., Kelleher, K. J., Chisolm, D. J., Comstock, R. D., Ferketich, A. K., & McBride, K. L. (2014). Understanding of informed consent by parents of children enrolled in a genetic biobank. Genetics in Medicine, 16(2), 141–148. doi:10.1038/gim.2013.86.
Lee, H., Deignan, J. L., Dorrani, N., Strom, S. P., Kantarci, S., Quintero-Rivera, F., et al. (2014). Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA, 312(18), 1880–1887. doi:10.1001/jama.2014.14604.
Levenseller, B. L., Soucier, D. J., Miller, V. A., Harris, D., Conway, L., & Bernhardt, B. A. (2014). Stakeholders’ opinions on the implementation of pediatric whole exome sequencing: implications for informed consent. Journal of Genetic Counseling, 23(4), 552–565. doi:10.1007/s10897-013-9626-y.
McCullough, L. B., Slashinski, M. J., McGuire, A. L., Street Jr., R. L., Eng, C. M., Gibbs, R. A., et al. (2016). Is whole-exome sequencing an ethically disruptive technology? Perspectives of pediatric oncologists and parents of pediatric patients with solid tumors. Pediatric Blood & Cancer, 63(3), 511–515. doi:10.1002/pbc.25815.
Miller, C. K., O’Donnell, D. C., Searight, H. R., & Barbarash, R. A. (1996). The deaconess informed consent comprehension test: an assessment tool for clinical research subjects. Pharmacotherapy, 16(5), 872–878.
Noll, S., Spitz, L., & Pierro, A. (2001). Additional medical information: prevalence, source, and benefit to parents. Journal of Pediatric Surgery, 36(5), 791–794. doi:10.1053/jpsu.2001.22962.
O’Daniel, J. M., & Lee, K. (2012). Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling. Cancer Journal, 18(4), 287–292. doi:10.1097/PPO.0b013e318262467e.
Oberg, J. A., Glade Bender, J. L., Cohn, E. G., Morris, M., Ruiz, J., Chung, W. K., et al. (2015). Overcoming challenges to meaningful informed consent for whole genome sequencing in pediatric cancer research. Pediatric Blood & Cancer, 62(8), 1374–1380. doi:10.1002/pbc.25520.
Ormond, K. E. (2013). From genetic counseling to "genomic counseling". Molecular Genetics & Genomic Medicine, 1(4), 189–193. doi:10.1002/mgg3.45.
Parkman, A. A., Foland, J., Anderson, B., Duquette, D., Sobotka, H., Lynn, M., et al. (2015). Public awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections. Journal of Genetic Counseling, 24(3), 512–521. doi:10.1007/s10897-014-9771-y.
Pinxten, W., & Howard, H. C. (2014). Ethical issues raised by whole genome sequencing. Best Practice & Research. Clinical Gastroenterology, 28(2), 269–279. doi:10.1016/j.bpg.2014.02.004.
Rabbani, B., Tekin, M., & Mahdieh, N. (2014). The promise of whole-exome sequencing in medical genetics. Journal of Human Genetics, 59(1), 5–15. doi:10.1038/jhg.2013.114.
Rigter, T., Henneman, L., Kristoffersson, U., Hall, A., Yntema, H. G., Borry, P., et al. (2013). Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics. Human Mutation, 34(10), 1322–1328. doi:10.1002/humu.22370.
Rigter, T., van Aart, C. J., Elting, M. W., Waisfisz, Q., Cornel, M. C., & Henneman, L. (2014). Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients. Clinical Genetics, 85(5), 417–422. doi:10.1111/cge.12299.
Sapp, J. C., Dong, D., Stark, C., Ivey, L. E., Hooker, G., Biesecker, L. G., & Biesecker, B. B. (2014). Parental attitudes, values, and beliefs toward the return of results from exome sequencing in children. Clinical Genetics, 85(2), 120–126. doi:10.1111/cge.12254.
Scollon, S., Bergstrom, K., Kerstein, R. A., Wang, T., Hilsenbeck, S. G., Ramamurthy, U., et al. (2014). Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients. Genome Medicine, 6(9), 69. doi:10.1186/s13073-014-0069-3.
Seltzer, M. M., Floyd, F., Song, J., Greenberg, J., & Hong, J. (2011). Midlife and aging parents of adults with intellectual and developmental disabilities: impacts of lifelong parenting. American Journal on Intellectual and Developmental Disabilities, 116(6), 479–499. doi:10.1352/1944-7558-116.6.479.
Shahmirzadi, L., Chao, E. C., Palmaer, E., Parra, M. C., Tang, S., & Gonzalez, K. D. (2014). Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing. Genetics in Medicine, 16(5), 395–399. doi:10.1038/gim.2013.153.
Tomlinson, A. N., Skinner, D., Perry, D. L., Scollon, S. R., Roche, M. I., & Bernhardt, B. A. (2016). "not tied up neatly with a bow": professionals’ challenging cases in informed consent for genomic sequencing. Journal of Genetic Counseling, 25(1), 62–72. doi:10.1007/s10897-015-9842-8.
Valencia, C. A., Husami, A., Holle, J., Johnson, J. A., Qian, Y., Mathur, A., et al. (2015). Clinical impact and cost-effectiveness of whole exome sequencing as a diagnostic tool: a pediatric Center’s experience. Front Pediatr, 3, 67. doi:10.3389/fped.2015.00067.
van El, C. G., Cornel, M. C., Borry, P., Hastings, R. J., Fellmann, F., Hodgson, S. V., et al. (2013). Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. European Journal of Human Genetics, 21(6), 580–584. doi:10.1038/ejhg.2013.46.
Weiner, C. (2014). Anticipate and communicate: ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the presidential Commission for the Study of bioethical issues). American Journal of Epidemiology, 180(6), 562–564. doi:10.1093/aje/kwu217.
Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., et al. (2013). Clinical whole-exome sequencing for the diagnosis of mendelian disorders. The New England Journal of Medicine, 369(16), 1502–1511. doi:10.1056/NEJMoa1306555.
Yang, Y., Muzny, D. M., Xia, F., Niu, Z., Person, R., Ding, Y., et al. (2014). Molecular findings among patients referred for clinical whole-exome sequencing. JAMA, 312(18), 1870–1879. doi:10.1001/jama.2014.14601.
Yu, J. H., Harrell, T. M., Jamal, S. M., Tabor, H. K., & Bamshad, M. J. (2014). Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing. American Journal of Human Genetics, 95(1), 77–84. doi:10.1016/j.ajhg.2014.06.004.
Acknowledgments
This publication was supported by a Research Award to the first author from the Division of Human Genetics at Cincinnati Children’s Hospital Medical Center.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Leandra K. Tolusso, Kathleen Collins, Xue Zhang, Jennifer R. Holle, C. Alexander Valencia, and Melanie F. Myers declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all participants for being included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Rights and permissions
About this article
Cite this article
Tolusso, L.K., Collins, K., Zhang, X. et al. Pediatric Whole Exome Sequencing: an Assessment of Parents’ Perceived and Actual Understanding.. J Genet Counsel 26, 792–805 (2017). https://doi.org/10.1007/s10897-016-0052-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-016-0052-9